1 "Viral immune evasion due to persistence of activated T cells without effector function" 188 : 2205-2213, 1998
2 "Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells" 2 : 52-58, 1996
3 "Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells" 4 : 328-332, 1998
4 "Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high dose bolus interleukin-2" 271 : 907-913, 1994
5 "The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing" 375 : 151-155, 1995
6 "Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy" 93 : 4102-4107, 1996
7 "Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells" 104 : 173-180, 1999
8 "Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells" 167 : 4844-4852, 2001
9 "Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer" 18 : 3883-3893, 2000
10 "Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma" 24 : 66-78, 2001
1 "Viral immune evasion due to persistence of activated T cells without effector function" 188 : 2205-2213, 1998
2 "Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells" 2 : 52-58, 1996
3 "Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells" 4 : 328-332, 1998
4 "Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high dose bolus interleukin-2" 271 : 907-913, 1994
5 "The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing" 375 : 151-155, 1995
6 "Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy" 93 : 4102-4107, 1996
7 "Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells" 104 : 173-180, 1999
8 "Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells" 167 : 4844-4852, 2001
9 "Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer" 18 : 3883-3893, 2000
10 "Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma" 24 : 66-78, 2001
11 "Optimizing dendritic cell-based anticancer immunotherapy:maturation state does have clinical impact" 24 : 1-18, 2003
12 "New perspectives on immunology and immunothe-rapy of melanoma" 20 : 5-7, 1999
13 "Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo" 95 : 9482-9487, 1998
14 "Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation" 93 : 728-736, 1999
15 "Mature dendritic cells boost functionally superior CD8(+)T-cell in humans without foreign helper epitopes" 105 : 9-14, 2000
16 "Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA:implications for cervical cancer immunotherapy" 23 : 412-418, 2000
17 "Immunotherapy of cancer with dendritic-cell-based vaccines" 46 : 82-87, 1998
18 "Immunotherapy for melanoma" 9 : 22-30, 2002
19 "Immunity against cancer:lessons learned from melanoma" 13 : 134-140, 2001
20 "Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma" 4 : 957-962, 1998
21 "High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy" 162 : 989-994, 1999
22 "Generation of tumor cell lysate- loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response" 52 : 67-79, 2003
23 "Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells" 110 : 441-448, 1998
24 "Dendritic cells:immunological sentinels with a central role in health and disease" 78 : 91-102, 2000
25 "Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment:downregulation by cytokines and bacterial products" 182 : 389-400, 1995
26 "Dendritic cells capture killed tumor cells and present their antigens to elicit tumor- specific immune responses" 165 : 3797-3803, 2000
27 "Dendritic cells and the control of immunity" 392 : 245-252, 1998
28 "Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs" 392 : 86-89, 1998
29 "Dendritic cell-based vaccines in cancer immunotherapy:an update on clinical and immunological results" 15 : 145-151, 2004
30 "Dendritic cell-based immunotherapy of prostate cancer" 18 : 109-119, 1998
31 "DC-based cancer immunotherapy:the sequel" 20 : 197-198, 1999
32 "Clinical observation of cutaneous malignant tumors and premalignant lesions over 15 years(1982-1996)" 37 : 1413-1422, 1999
33 "Cellular and humoral immune response in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells" 161 : 777-782, 1999
34 "CD4 T cells and their role in antitumor immune responses" 189 : 753-756, 1999
35 "Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells" 193 : 233-238, 2001
36 "A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone" 316 : 889-897, 1987
37 "A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection" 93 : 243-251, 2001
국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
KISS
